Rifampin and Pyrazinamide for Treatment of Latent Tuberculosis Infection-Reference-Cited by-同舟云学术

Rifampin and Pyrazinamide for Treatment of Latent Tuberculosis Infection

Published:2003-03-15 Issue:6 Volume:167 Page:809-810
ISSN:1073-449X
Container-title:American Journal of Respiratory and Critical Care Medicine
language:en
Short-container-title:Am J Respir Crit Care Med

Author:

Jasmer Robert M.,Daley Charles L.

Publisher

American Thoracic Society

Subject

Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference14 articles.

1. Ferebee SH. Controlled chemoprophylaxis trials in tuberculosis: a general review.Adv Tuberc Res1970;17:28–106.

2. International Union Against Tuberculosis Committee on Prophylaxis. Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up in the IUAT trial.Bull World Health Organ1982;60:555–564.

3. Nolan CM, Goldberg SV, Buskin SE. Hepatotoxicity associated with isoniazid preventive therapy: a 7-year survey from a public health tuberculosis clinic.JAMA1999;17:281:1014–1018.

4. Hepatotoxicity from Rifampin Plus Pyrazinamide

5. Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An open‐label study to explore the optimal design of CYP3A drug–drug interaction clinical trials in healthy Chinese people;Pharmacology Research & Perspectives;2024-07-28

2. Mind the gap – Managing tuberculosis across the disease spectrum;eBioMedicine;2022-04

3. The Biological and Clinical Aspects of a Latent Tuberculosis Infection;Tropical Medicine and Infectious Disease;2022-03-08

4. Mycobacterial infections in solid organ transplant recipients;Korean Journal of Transplantation;2021-12-31

5. Screening for latent tuberculosis infection prior to biologic therapy in patients with chronic immune-mediated inflammatory diseases (IMID): Interferon-gamma release assay (IGRA) versus tuberculin skin test (TST);The Egyptian Rheumatologist;2019-07